Viewing data from:

CRYSELLE

ANDA

ETHINYL ESTRADIOL; NORGESTREL | A075840 | DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC

2 strengths0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Cryselle (2023)

Total Spending

$281K

Total Claims

9,122

Beneficiaries

1,622

Avg Cost/Unit

$0.67

Spending Trend

$366K(2019)→$386K(2020)→$340K(2021)→$304K(2022)→$281K(2023)

YoY Change:+2.9%

5yr CAGR:+0.5%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 15, 2003	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 0.03MG;0.3MG

0 patents0 exclusivities▴

TABLET;ORAL-21 | Approved: Nov 30, 2001

No patent or exclusivity listings for this strength.

#002 — 0.03MG;0.3MG

0 patents0 exclusivities▾

TABLET;ORAL-28 | Approved: Nov 30, 2001